---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-003953"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:33:43.524583+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix effects 1-for-20 reverse stock split, reducing outstanding shares to ~1.64M

## Summary
- Reverse split ratio 1-for-20 effective 4:05 p.m. ET on Feb 8, 2023; adjusted trading starts Feb 9.
- Outstanding shares reduced from 32,894,359 to approximately 1,644,718, with fractional shares rounded up.
- Authorized shares unchanged at 40M; par value remains $0.001 per share.
- Proportional adjustments to equity awards, warrants, and convertible securities exercise prices and shares.
- Stock symbol remains NAOV; new CUSIP 63008J603.

## SEC filing metadata
- accession: 0001493152-23-003953
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223003953/0001493152-23-003953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223003953/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-003953
- JSON: https://secwatch.observer/filing/0001493152-23-003953.json
- Plain text: https://secwatch.observer/filing/0001493152-23-003953.txt

## Key facts
- Governance Changes
  ENvue Medical, Inc.: Reverse stock split of common stock at a 1-for-20 ratio via Certificate of Amendment to Amended and Restated Certificate of Incorporation (effective 2023-02-08).
  - Change: charter amendment
  - Effective: 2023-02-08
  source text: On February 8, 2023, NanoVibronix, Inc. (the “Company”) filed a Certificate of Amendment of the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-20 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on February 8, 2023 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000149315223003953/0001493152-23-003953-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.